Pyxis Oncology, Inc. (PYXS) Misses Q4 EPS by 100c

Pyxis Oncology, Inc. (NASDAQ: PYXS) reported Q4 EPS of ($1.32), $1.00 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Pyxis Oncology, Inc. (PYXS) click here.

You May Also Be Interested In

• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Active options: TSLA NVDA SPCX MU AAPL AMD INTC AMZN
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results